Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Publication year range
1.
Braz J Infect Dis ; 5(6): 332-8, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11980596

ABSTRACT

Hyperlipidemia has been frequently recorded as a side effect of treating HIV patients with protease inhibitors (PI). This study was initiated to analyze the modifications on blood lipids in HIV-patients receiving PI and the safety and efficacy of the treatment with fenofibrate. Total (TC) and HDL-cholesterol, triglycerides (TG), and CD(4)(+) T-cell counts were measured in 30 HAART-naive patients (Group I) before and after PI introduction. In a second phase of the study, the effects of fenofibrate on lipids, CPK, CD(4)(+), and viral load were determined in 13 patients (Group II) with elevated TC or TG. In Group I, 60% of the patients showed TC or TG elevations. Average increments of 31% and 146% in TC and TG respectively (p<0.0006 and p<0.0001) were observed. In Group II, fenofibrate treatment was associated with decrements of 6.6% (TC) and 45.7% (TG) (p=0.07 and 0.0002) and no modifications on CPK, CD(4)(+), and viral load. In conclusion, hyperlipidemia is common during the treatment of HIV with protease inhibitors, and fenofibrate appears to be an effective and safe choice for its treatment.


Subject(s)
Fenofibrate/therapeutic use , HIV Infections/drug therapy , HIV Protease Inhibitors/adverse effects , Hyperlipidemias/drug therapy , Hypolipidemic Agents/therapeutic use , Adult , Aged , CD4 Lymphocyte Count , Cholesterol/blood , Female , HIV-1/physiology , Humans , Hyperlipidemias/chemically induced , Male , Middle Aged , Triglycerides/blood , Viral Load
2.
Arq. bras. cardiol ; 69(4): 251-4, out. 1997. ilus
Article in Portuguese | LILACS | ID: lil-234352

ABSTRACT

Paciente feminina, 67 anos, internada por infarto agudo do miocárdio de parede lateral, com edema agudo de pulmão e evolução para choque cardiogênico nas primeiras horas. Ecocardiograma transesofágico e ressonância magnética confirmaram o diagnóstico de pseudoaneurisma de ventrículo esquedo. A paciente foi submentida a tratamento cirúrgico com sucesso.


Subject(s)
Humans , Female , Aged , Aneurysm, False/surgery , Ventricular Dysfunction, Left , Postoperative Care , Magnetic Resonance Spectroscopy/methods , Treatment Outcome
3.
Arq Bras Cardiol ; 69(4): 251-4, 1997 Oct.
Article in Portuguese | MEDLINE | ID: mdl-9595718

ABSTRACT

We describe the case of a 61 year-old female patient admitted to the hospital with acute lateral myocardial infarction, in pulmonary edema, who evolved to cardiogenic shock in the first hours. Transesophageal echodoppler-cardiogram and nuclear magnetic resonance imaging showed the diagnosis of a left ventricular pseudoaneurysm. Surgical repair was successfully undertaken.


Subject(s)
Aneurysm, False/diagnosis , Heart Ventricles/surgery , Magnetic Resonance Imaging , Aneurysm, False/surgery , Female , Humans
4.
Arq Bras Cardiol ; 67(5): 351-3, 1996 Nov.
Article in Portuguese | MEDLINE | ID: mdl-9239873

ABSTRACT

A 21-year-old white man presented with cardiogenic shock and refractory pulmonary congestion. At the transthoracic echocardiogram a subvalvar left ventricular aneurysm of the inferior wall with severe mitral regurgitation was observed. The outcome was favorable after surgical correction of the mitral regurgitation and of the subvalvar aneurysm. We emphasize that, whenever possible, valvar repair is better than mitral replacement, since annulus tissue fragility causes suturing of the mitral prosthesis to be difficult.


Subject(s)
Heart Aneurysm/complications , Mitral Valve Insufficiency/etiology , Adult , Electrocardiography , Heart Aneurysm/surgery , Heart Ventricles , Humans , Male , Mitral Valve Insufficiency/surgery
5.
Am J Cardiol ; 74(7): 691-5, 1994 Oct 01.
Article in English | MEDLINE | ID: mdl-7942527

ABSTRACT

Conduit artery distensibility affects the pulsatile component of afterload and may contribute to impaired left ventricular function in patients with congestive heart failure (CHF). The objectives of this study were to (1) determine whether arterial distensibility is reduced in patients with CHF, and (2) determine whether decreased arterial compliance is related to an abnormality in vascular wall structure (i.e., wall thickness or excessive levels of circulating neurohumoral vasoconstrictors, or both). The study participants included 40 patients with CHF secondary to idiopathic dilated cardiomyopathy and 33 age-matched healthy volunteers. High-resolution ultrasonography was performed to directly visualize the common carotid artery and measure its diameter and wall thickness. Its elastic properties were determined by relating changes in arterial diameter to changes in pressure generated with each heart beat. Carotid artery distensibility was less (14.1 +/- 1.1 vs 25.3 +/- 1.6 10(-6).N-1.m2, p < 0.001) and Young's modulus of elasticity was greater (3.99 +/- 0.51 vs 2.29 +/- 0.23 10(5).N.m-2, p < 0.005) in patients with CHF than in normal subjects. Also, carotid artery wall thickness was increased in patients with CHF. When the entire population was considered, age, wall thickness, and plasma norepinephrine and aldosterone concentrations correlated inversely with distensibility, whereas age and plasma norepinephrine concentration correlated directly with elasticity. Among normal subjects, only age correlated inversely with distensibility; among patients with CHF, only plasma norepinephrine concentration correlated with elasticity. It is concluded that carotid artery distensibility is reduced in patients with CHF.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Cardiomyopathy, Dilated/complications , Carotid Artery, Common/physiopathology , Heart Failure/physiopathology , Adult , Aged , Aldosterone/blood , Cardiomyopathy, Dilated/blood , Carotid Artery, Common/diagnostic imaging , Carotid Artery, Common/pathology , Compliance , Female , Heart Failure/diagnostic imaging , Heart Failure/etiology , Humans , Male , Middle Aged , Norepinephrine/blood , Regression Analysis , Ultrasonography
6.
Arq Bras Cardiol ; 62(6): 427-30, 1994 Jun.
Article in Portuguese | MEDLINE | ID: mdl-7826236

ABSTRACT

Fulminant hepatic failure is a complication of severe cardiocirculatory failure, with high morbidity and mortality, and is frequently misdiagnosed as fulminant viral hepatitis. We report three cases of patients with chronic severe heart failure who developed cardiogenic shock complicated by elevation of aminotransferase levels above 1,000 soon after the most severe episode of hypotension. All the three patients presented regression of hepatic enzymes 72h after admission. Two patients developed hepatic encephalopathy and renal failure. One underwent the implantation of an artificial left ventricle, followed by orthotopic heart transplantation. One died of systemic multiple organ failure, after he had showed improvement on his hepatic profile, and one was sent to the ward, after 15 days with marked improvement on his clinical status and no signs of hepatic disease.


Subject(s)
Cardiomyopathy, Dilated/complications , Liver Failure, Acute/etiology , Shock, Cardiogenic/etiology , Adult , Alanine Transaminase/analysis , Humans , Liver Failure, Acute/enzymology , Male , Shock, Cardiogenic/enzymology
7.
Arq Bras Cardiol ; 62(3): 155-7, 1994 Mar.
Article in Portuguese | MEDLINE | ID: mdl-7980075

ABSTRACT

PURPOSE: To evaluate the toxicity of thiocyanate induced by the infusion of sodium nitroprusside in patients with severe congestive failure. METHODS: We studied 23 patients with congestive heart failure, in class IV (NYHA) under continuous infusion of sodium nitroprusside with doses varying between 0.5 and 5.5 micrograms/kg/min. Clinical evaluation, thiocyanate serum dosage and laboratorial evaluation of renal, hepatic and pulmonary functions were done. RESULTS: Seventeen patients (74%) presented toxic levels of thiocyanate (over 10 micrograms/ml), with the average of 29.9 +/- 4.4 micrograms/ml. Only renal function was related to the presence of intoxication. Clinical evaluation was not accurate to diagnose the thiocyanate toxicity in the patients. CONCLUSION: Sodium nitroprusside is potentially toxic, especially when the renal function is abnormal. Thiocyanate dosage is useful in diagnosing nitroprusside induced toxicity and then it contributes to an adequate treatment and prevention of clinical toxicity.


Subject(s)
Heart Failure/blood , Nitroprusside/administration & dosage , Thiocyanates/poisoning , Adult , Female , Humans , Infusions, Intravenous , Male , Middle Aged , Nitroprusside/adverse effects , Nitroprusside/metabolism , Retrospective Studies , Time Factors
8.
In. Sociedade de Cardiologia do Estado de Säo Paulo. Cardiologia: atualizaçäo e reciclagem. Rio de Janeiro, Atheneu, 1994. p.755-61, tab, graf.
Monography in Portuguese | LILACS | ID: lil-199297

ABSTRACT

O choque cardiogênico caracteriza-se quando uma severa disfunçäo miocárdica provoca hipoperfusäo tecidual e falência orgânica. Os critérios exatos para a presença de choque cardiogênico variam muito na literatura. Além disso é extremamente importante comparar o grau da disfunçäo miocárdica quando se analisam os resultados de diferentes procedimentos. Em 1973, importante estudo multicêntrico estabeleceu os seguintes critérios para a definiçäo de choque cardiogênico: - pressäo arterial sistólica < 80 mmHg (intra-arterial); - débito urinário < 20 ml/h ou confusäo mental; - pressäo de enchimento ventricular > 12 mmHg; - pressäo venosa central > 10 cm H20. Esta definiçäo tem grande utilidade clínica pois inclui a classificaçäo de Kilip para o infarto agudo do miocárdio. Além disso, incorpora os três principais componentes do choque cardiogênico: 1) comprometimento da funçäo ventricular; 2) evidência de falência orgânica como resultado do decréscimo da perfusäo tecidual; e 3) exclusäo de hipovolemia e outras causas do choque. Uma vez que esta definiçäo já foi largamente aplicada com sucesso em estudos prospectivos, pode ser considerada padräo para estudos clínicos futuros.


Subject(s)
Humans , Shock, Cardiogenic/history , Shock, Cardiogenic/etiology , Shock, Cardiogenic/physiopathology , Shock, Cardiogenic/metabolism , Shock, Cardiogenic/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...